Friday, February 27, 2015 8:49:14 AM
1)I think they have (or at least had)a pretty substantial amount of goods in the last report. IF they sold all that inventory, there would probably not be a need to dilute. IF they didn't sell them, then they would not need to produce more.
2)How much capital do you think they need to submit a 510k? That is all the final order would allow for. Once they have something generally approved (rx and/or Acti) with the FDA, I would imagine that financing and distribution (maybe an agreement?) is the easy part.
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM